+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Submucosal Lifting Agent Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 214 Pages
  • January 2025
  • Region: Global
  • Fairfield Market Research
  • ID: 6050329
The global submucosal lifting agent market is projected to experience steady expansion, driven by increasing demand for advanced gastrointestinal endoscopic procedures. The market is anticipated to reach USD 1.26 billion by 2025 and USD 2.07 billion by 2032, registering a CAGR of 7.39% during the forecast period. The rising prevalence of gastrointestinal diseases, coupled with the adoption of minimally invasive techniques, continues to fuel demand for innovative submucosal lifting agents that enhance safety and efficacy in endoscopic interventions.

Market Insights

Submucosal lifting agents play a critical role in facilitating endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) by creating a safe separation between mucosal and submucosal layers. These agents help in improved visualization, precise lesion removal, and minimized risk of perforation, making them indispensable in gastroenterology.

Key Market Drivers

  • Rising Gastrointestinal Disease Prevalence: Increasing cases of colorectal neoplasms and early-stage gastrointestinal cancers drive demand for submucosal lifting agents in diagnostic and therapeutic endoscopy.
  • Advancements in Endoscopic Techniques: Continuous innovations in endoscopic technology have heightened the importance of lifting agents, ensuring safer and more effective procedures.
  • Growing Preference for Minimally Invasive Procedures: Endoscopic interventions are increasingly preferred over traditional surgeries, leading to higher adoption of submucosal lifting agents.
  • Regulatory Compliance and Standardization: Stricter quality control measures are ensuring the safety and efficacy of new formulations, influencing market growth.

Business Opportunities

  • Innovative Formulations: Research and development efforts focus on improving agent viscosity, prolonging lifting duration, and minimizing side effects, presenting lucrative opportunities for manufacturers.
  • Collaborations with Endoscopy Equipment Manufacturers: Strategic partnerships between lifting agent developers and medical device companies will create comprehensive solutions for healthcare providers.
  • Expansion in Emerging Markets: South Asia and the Pacific regions offer substantial growth potential due to rising healthcare investments and an increasing burden of gastrointestinal diseases.

Regional Analysis

  • Europe: The dominant market due to its well-established healthcare infrastructure and widespread adoption of endoscopic procedures.
  • South Asia & Pacific: The fastest-growing region, driven by improving healthcare accessibility and a rising prevalence of gastrointestinal diseases.
  • North America: A significant market with strong demand for advanced endoscopic interventions and the presence of key industry players.
  • Latin America & Middle East & Africa: Emerging regions with gradual improvements in endoscopic procedure accessibility and awareness.

Key Players

Prominent companies leading the submucosal lifting agent market include:

  • Laborie
  • STERIS
  • Olympus America
  • Medtronic
  • Boston Scientific Corporation
  • Omnimed Ltd™
  • COSMO PHARMACEUTICALS
  • Micro-Tech Endoscopy
  • Ovesco Endoscopy AG

Recent Developments

  • AscentX Medical Innovations: The company developed a minimally invasive endoscopic injection procedure for treating medical conditions, including Gastroesophageal reflux disease, marking a breakthrough in the market.
  • Boston Scientific’s ORISE Gel Recall (October 2022): The recall impacted the industry by emphasizing stringent quality standards and regulatory compliance for lifting agents used in endoscopic procedures.

Market Segmentation

  • By Ingredient: Sodium Hyaluronate, Poloxamers, Cellulose, Absorbable Starch Polymers, Poloxamer 188, and Polyoxyl-15-hydroxystearate, among others.
  • By Type: Normal saline, Dextrose water, Hydroxypropyl methylcellulose, Hydroxyethyl starch, Hyaluronic acid, Fibrinogen mixture, Succinylated gelatin, Eleview, and ORISE gel.
  • By Application: Polyps, Adenomas, Early-stage Cancers, Gastrointestinal Mucosal Lesions, and Others.
  • By End-Use: Hospitals, Specialty Clinics, Surgical Centers, and Others.
  • By Region: North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Submucosal Lifting Agent Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. PESTLE Analysis
3. Price Analysis, 2025
3.1. Global Average Price Analysis, by Ingredient/ Material, US$ Per Unit, 2025
3.2. Prominent Factor Affecting Submucosal Lifting Agent Prices
3.3. Global Average Price Analysis, by Region, US$ Per Unit
4. Global Submucosal Lifting Agent Market Outlook, 2019 - 2032
4.1. Global Submucosal Lifting Agent Market Outlook, by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
4.1.1. Key Highlights
4.1.1.1. Poloxamer 188 and Polyoxyl-15-hydroxystearate
4.1.1.2. Gellan gum and Polysaccharide
4.1.1.3. Sodium Hyaluronate
4.1.1.4. Cellulose
4.1.1.5. Absorbable Starch Polymers
4.1.1.6. Poloxamers
4.2. Global Submucosal Lifting Agent Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
4.2.1. Key Highlights
4.2.1.1. Normal saline
4.2.1.2. Dextrose water
4.2.1.3. Hydroxypropyl methylcellulose
4.2.1.4. Hydroxyethyl starch
4.2.1.5. Hyaluronic acid
4.2.1.6. Fibrinogen mixture
4.2.1.7. Succinylated gelatin
4.2.1.8. Eleview and ORISE gel
4.3. Global Submucosal Lifting Agent Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
4.3.1. Key Highlights
4.3.1.1. Polyps
4.3.1.2. Adenomas
4.3.1.3. Early-stage Cancers
4.3.1.4. Gastrointestinal Mucosal Lesions
4.3.1.5. Others
4.4. Global Submucosal Lifting Agent Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
4.4.1. Key Highlights
4.4.1.1. Hospitals
4.4.1.2. Specialty Clinics
4.4.1.3. Surgical Centers
4.4.1.4. Others
4.5. Global Submucosal Lifting Agent Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
4.5.1. Key Highlights
4.5.1.1. North America
4.5.1.2. Europe
4.5.1.3. Asia Pacific
4.5.1.4. Latin America
4.5.1.5. Middle East & Africa
5. North America Submucosal Lifting Agent Market Outlook, 2019 - 2032
5.1. North America Submucosal Lifting Agent Market Outlook, by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
5.1.1. Key Highlights
5.1.1.1. Poloxamer 188 and Polyoxyl-15-hydroxystearate
5.1.1.2. Gellan gum and Polysaccharide
5.1.1.3. Sodium Hyaluronate
5.1.1.4. Cellulose
5.1.1.5. Absorbable Starch Polymers
5.1.1.6. Poloxamers
5.2. North America Submucosal Lifting Agent Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
5.2.1. Key Highlights
5.2.1.1. Normal saline
5.2.1.2. Dextrose water
5.2.1.3. Hydroxypropyl methylcellulose
5.2.1.4. Hydroxyethyl starch
5.2.1.5. Hyaluronic acid
5.2.1.6. Fibrinogen mixture
5.2.1.7. Succinylated gelatin
5.2.1.8. Eleview and ORISE gel
5.3. North America Submucosal Lifting Agent Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
5.3.1. Key Highlights
5.3.1.1. Polyps
5.3.1.2. Adenomas
5.3.1.3. Early-stage Cancers
5.3.1.4. Gastrointestinal Mucosal Lesions
5.3.1.5. Others
5.4. North America Submucosal Lifting Agent Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
5.4.1. Key Highlights
5.4.1.1. Hospitals
5.4.1.2. Specialty Clinics
5.4.1.3. Surgical Centers
5.4.1.4. Others
5.5. North America Submucosal Lifting Agent Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
5.5.1. Key Highlights
5.5.1.1. U.S. Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
5.5.1.2. U.S. Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
5.5.1.3. U.S. Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
5.5.1.4. U.S. Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
5.5.1.5. Canada Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
5.5.1.6. Canada Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
5.5.1.7. Canada Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
5.5.1.8. Canada Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Europe Submucosal Lifting Agent Market Outlook, 2019 - 2032
6.1. Europe Submucosal Lifting Agent Market Outlook, by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.1.1. Key Highlights
6.1.1.1. Poloxamer 188 and Polyoxyl-15-hydroxystearate
6.1.1.2. Gellan gum and Polysaccharide
6.1.1.3. Sodium Hyaluronate
6.1.1.4. Cellulose
6.1.1.5. Absorbable Starch Polymers
6.1.1.6. Poloxamers
6.2. Europe Submucosal Lifting Agent Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.2.1. Key Highlights
6.2.1.1. Normal saline
6.2.1.2. Dextrose water
6.2.1.3. Hydroxypropyl methylcellulose
6.2.1.4. Hydroxyethyl starch
6.2.1.5. Hyaluronic acid
6.2.1.6. Fibrinogen mixture
6.2.1.7. Succinylated gelatin
6.2.1.8. Eleview and ORISE gel
6.3. Europe Submucosal Lifting Agent Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.3.1. Key Highlights
6.3.1.1. Polyps
6.3.1.2. Adenomas
6.3.1.3. Early-stage Cancers
6.3.1.4. Gastrointestinal Mucosal Lesions
6.3.1.5. Others
6.4. Europe Submucosal Lifting Agent Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.4.1.1. Hospitals
6.4.1.2. Specialty Clinics
6.4.1.3. Surgical Centers
6.4.1.4. Others
6.5. Europe Submucosal Lifting Agent Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1. Key Highlights
6.5.1.1. Germany Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1.2. Germany Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1.3. Germany Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1.4. Germany Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1.5. U.K. Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1.6. U.K. Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1.7. U.K. Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1.8. U.K. Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1.9. France Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1.10. France Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1.11. France Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1.12. France Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1.13. Italy Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1.14. Italy Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1.15. Italy Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1.16. Italy Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1.17. Turkey Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1.18. Turkey Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1.19. Turkey Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1.20. Turkey Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1.21. Russia Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1.22. Russia Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1.23. Russia Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1.24. Russia Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1.25. Rest of Europe Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1.26. Rest of Europe Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1.27. Rest of Europe Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.1.28. Rest of Europe Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Asia Pacific Submucosal Lifting Agent Market Outlook, 2019 - 2032
7.1. Asia Pacific Submucosal Lifting Agent Market Outlook, by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.1.1. Key Highlights
7.1.1.1. Poloxamer 188 and Polyoxyl-15-hydroxystearate
7.1.1.2. Gellan gum and Polysaccharide
7.1.1.3. Sodium Hyaluronate
7.1.1.4. Cellulose
7.1.1.5. Absorbable Starch Polymers
7.1.1.6. Poloxamers
7.2. Asia Pacific Submucosal Lifting Agent Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.2.1. Key Highlights
7.2.1.1. Normal saline
7.2.1.2. Dextrose water
7.2.1.3. Hydroxypropyl methylcellulose
7.2.1.4. Hydroxyethyl starch
7.2.1.5. Hyaluronic acid
7.2.1.6. Fibrinogen mixture
7.2.1.7. Succinylated gelatin
7.2.1.8. Eleview and ORISE gel
7.3. Asia Pacific Submucosal Lifting Agent Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.3.1. Key Highlights
7.3.1.1. Polyps
7.3.1.2. Adenomas
7.3.1.3. Early-stage Cancers
7.3.1.4. Gastrointestinal Mucosal Lesions
7.3.1.5. Others
7.4. Asia Pacific Submucosal Lifting Agent Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.4.1. Key Highlights
7.4.1.1. Hospitals
7.4.1.2. Specialty Clinics
7.4.1.3. Surgical Centers
7.4.1.4. Others
7.5. Asia Pacific Submucosal Lifting Agent Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.5.1. Key Highlights
7.5.1.1. China Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.5.1.2. China Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.5.1.3. China Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.5.1.4. China Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.5.1.5. Japan Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.5.1.6. Japan Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.5.1.7. Japan Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.5.1.8. Japan Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.5.1.9. South Korea Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.5.1.10. South Korea Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.5.1.11. South Korea Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.5.1.12. South Korea Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.5.1.13. India Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.5.1.14. India Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.5.1.15. India Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.5.1.16. India Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.5.1.17. Southeast Asia Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.5.1.18. Southeast Asia Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.5.1.19. Southeast Asia Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.5.1.20. Southeast Asia Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.5.1.21. Rest of Asia Pacific Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.5.1.22. Rest of Asia Pacific Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.5.1.23. Rest of Asia Pacific Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.5.1.24. Rest of Asia Pacific Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Latin America Submucosal Lifting Agent Market Outlook, 2019 - 2032
8.1. Latin America Submucosal Lifting Agent Market Outlook, by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.1.1. Key Highlights
8.1.1.1. Poloxamer 188 and Polyoxyl-15-hydroxystearate
8.1.1.2. Gellan gum and Polysaccharide
8.1.1.3. Sodium Hyaluronate
8.1.1.4. Cellulose
8.1.1.5. Absorbable Starch Polymers
8.1.1.6. Poloxamers
8.2. Latin America Submucosal Lifting Agent Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.2.1.1. Normal saline
8.2.1.2. Dextrose water
8.2.1.3. Hydroxypropyl methylcellulose
8.2.1.4. Hydroxyethyl starch
8.2.1.5. Hyaluronic acid
8.2.1.6. Fibrinogen mixture
8.2.1.7. Succinylated gelatin
8.2.1.8. Eleview and ORISE gel
8.3. Latin America Submucosal Lifting Agent Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.3.1. Key Highlights
8.3.1.1. Polyps
8.3.1.2. Adenomas
8.3.1.3. Early-stage Cancers
8.3.1.4. Gastrointestinal Mucosal Lesions
8.3.1.5. Others
8.4. Latin America Submucosal Lifting Agent Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.4.1. Key Highlights
8.4.1.1. Hospitals
8.4.1.2. Specialty Clinics
8.4.1.3. Surgical Centers
8.4.1.4. Others
8.5. Latin America Submucosal Lifting Agent Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.5.1. Key Highlights
8.5.1.1. Brazil Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.5.1.2. Brazil Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.5.1.3. Brazil Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.5.1.4. Brazil Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.5.1.5. Mexico Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.5.1.6. Mexico Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.5.1.7. Mexico Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.5.1.8. Mexico Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.5.1.9. Argentina Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.5.1.10. Argentina Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.5.1.11. Argentina Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.5.1.12. Argentina Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.5.1.13. Rest of Latin America Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.5.1.14. Rest of Latin America Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.5.1.15. Rest of Latin America Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.5.1.16. Rest of Latin America Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Middle East & Africa Submucosal Lifting Agent Market Outlook, 2019 - 2032
9.1. Middle East & Africa Submucosal Lifting Agent Market Outlook, by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.1.1. Key Highlights
9.1.1.1. Poloxamer 188 and Polyoxyl-15-hydroxystearate
9.1.1.2. Gellan gum and Polysaccharide
9.1.1.3. Sodium Hyaluronate
9.1.1.4. Cellulose
9.1.1.5. Absorbable Starch Polymers
9.1.1.6. Poloxamers
9.2. Middle East & Africa Submucosal Lifting Agent Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.2.1. Key Highlights
9.2.1.1. Normal saline
9.2.1.2. Dextrose water
9.2.1.3. Hydroxypropyl methylcellulose
9.2.1.4. Hydroxyethyl starch
9.2.1.5. Hyaluronic acid
9.2.1.6. Fibrinogen mixture
9.2.1.7. Succinylated gelatin
9.2.1.8. Eleview and ORISE gel
9.3. Middle East & Africa Submucosal Lifting Agent Market Outlook, by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.3.1. Key Highlights
9.3.1.1. Polyps
9.3.1.2. Adenomas
9.3.1.3. Early-stage Cancers
9.3.1.4. Gastrointestinal Mucosal Lesions
9.3.1.5. Others
9.4. Middle East & Africa Submucosal Lifting Agent Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.4.1. Key Highlights
9.4.1.1. Hospitals
9.4.1.2. Specialty Clinics
9.4.1.3. Surgical Centers
9.4.1.4. Others
9.5. Middle East & Africa Submucosal Lifting Agent Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.5.1. Key Highlights
9.5.1.1. GCC Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.5.1.2. GCC Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.5.1.3. GCC Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.5.1.4. GCC Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.5.1.5. South Africa Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.5.1.6. South Africa Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.5.1.7. South Africa Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.5.1.8. South Africa Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.5.1.9. Egypt Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.5.1.10. Egypt Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.5.1.11. Egypt Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.5.1.12. Egypt Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.5.1.13. Nigeria Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.5.1.14. Nigeria Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.5.1.15. Nigeria Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.5.1.16. Nigeria Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.5.1.17. Rest of Middle East & Africa Submucosal Lifting Agent Market by Ingredient, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.5.1.18. Rest of Middle East & Africa Submucosal Lifting Agent Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.5.1.19. Rest of Middle East & Africa Submucosal Lifting Agent Market by Application, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.5.1.20. Rest of Middle East & Africa Submucosal Lifting Agent Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
9.5.2. BPS Analysis/Market Attractiveness Analysis
10. Competitive Landscape
10.1. Company Market Share Analysis, 2025
10.2. Competitive Dashboard
10.3. Company Profiles
10.3.1. Laborie
10.3.1.1. Company Overview
10.3.1.2. Product Portfolio
10.3.1.3. Financial Overview
10.3.1.4. Business Strategies and Development
10.3.2. STERIS
10.3.2.1. Company Overview
10.3.2.2. Product Portfolio
10.3.2.3. Financial Overview
10.3.2.4. Business Strategies and Development
10.3.3. Olympus America
10.3.3.1. Company Overview
10.3.3.2. Product Portfolio
10.3.3.3. Financial Overview
10.3.3.4. Business Strategies and Development
10.3.4. Medtronic
10.3.4.1. Company Overview
10.3.4.2. Product Portfolio
10.3.4.3. Financial Overview
10.3.4.4. Business Strategies and Development
10.3.5. Boston Scientific Corporation
10.3.5.1. Company Overview
10.3.5.2. Product Portfolio
10.3.5.3. Financial Overview
10.3.5.4. Business Strategies and Development
10.3.6. Omnimed Ltd
10.3.6.1. Company Overview
10.3.6.2. Product Portfolio
10.3.6.3. Financial Overview
10.3.6.4. Business Strategies and Development
10.3.7. COSMO PHARMACEUTICALS
10.3.7.1. Company Overview
10.3.7.2. Product Portfolio
10.3.7.3. Financial Overview
10.3.7.4. Business Strategies and Development
10.3.8. Ovesco Endoscopy AG
10.3.8.1. Company Overview
10.3.8.2. Product Portfolio
10.3.8.3. Financial Overview
10.3.8.4. Business Strategies and Development
10.3.9. Others
10.3.9.1. Company Overview
10.3.9.2. Product Portfolio
10.3.9.3. Financial Overview
10.3.9.4. Business Strategies and Development
11. Appendix
11.1. Research Methodology
11.2. Report Assumptions
11.3. Acronyms and Abbreviations

Companies Mentioned

  • Laborie
  • STERIS
  • Olympus America
  • Medtronic
  • Boston Scientific Corporation
  • Omnimed Ltd™
  • COSMO PHARMACEUTICALS
  • Micro-Tech Endoscopy
  • Ovesco Endoscopy AG

Methodology

Loading
LOADING...